Effects of sham-controlled double blind transcranial direct current - PowerPoint PPT Presentation

Effects of sham-controlled double blind transcranial direct current stimulation in patients with disorders of consciousness XXth World Congress of Neurology Marrakesh, Morocco 16 November 2011 THIBAUT Aurore PhD candidate Coma Science Group Cyclotron Research Centre & Neurology Dept & University Hospital of Liège Belgium www.comascience.org

disorders of consciousness | behavioural evaluation | electrophysiology | neuroimaging | methods, ethics & quality of life | perspectives Introduction | Materials and Methods | Results │ Discussion Patients VEGETATIVE COMA NORMAL MINIMALLY STATE/ CONSCIOUSNESS CONSCIOUS UNRESPONSIVE STATE WAKEFULNESS SYNDROME AWARENESS AWARENESS AWARENESS AWARENESS AROUSAL AROUSAL AROUSAL AROUSAL Laureys, Owen and Schiff Lancet Neurology, 2005 www.comascience.org Laureys et al, BMC Medicine 2010 Demertzi et al, Exp Rev Neurother, 2008

Introduction | Materials and Methods | Results │ Discussion Why direct current stimulation? Stimulation Population Effects Authors Prefrontal Healthy subjects Memory Marshall et al, J Neurosci 2004 cortex Alzheimer’s patients Memory Ferrucci et al, Neurology 2008 Stroke patients Attention Jo et al, Am J Phys Med Rehabil 2009 Aphasic patients Language Baker et al, Stroke 2010 • Non-invasive • Easy to apply • Cheap equipment www.comascience.org

Introduction | Materials and Methods | Results │ Discussion Methods  Design: sham-controlled double blind  4 CRS-R: pre-post tDCS/pre-post sham  Patients  55 patients (16 women; aged 43 ± 18 y)  25 VS/UWS, 30 MCS  25 traumatic / 30 non-traumatic DC Stimulator Plus  Outcome measure  Coma Recovery Scale-Revised (CRS-R, Giacino 2004)  Hypothesis: tDCS responders:  CRS-R total tDCS > pre-tDCS, sham, pre-sham  Statistical analysis: ANOVA (Stata) www.comascience.org

Introduction | Materials and Methods | Results | Discussion | Group data (n=55) ** * Interactions • MCS>VS, p=0.026 • Acute> chronic, p=0.004 • Etiology, p=0.37 0 ** p<.001 pre tDCS post tDCS pre sham post sham * p <.05 www.comascience.org

Introduction | Materials and Methods | Results | Discussion | VS/UWS vs. MCS MCS VS/UWS * 23 23 17 responders 22 22 21 21 • 15 MCS (7 acute,8 chronic) 20 20 19 19 • 2 VS/UWS (acute) 18 18 17 17 16 16 15 15 CRS-R scores CRS-R scores 14 14 13 13 12 12 11 11 10 10 9 9 8 8 7 7 6 6 5 5 4 4 Trauma 3 3 Non trauma 2 2 Chronic 1 1 0 0 Acute pre tDCS post tDCS pre tDCS post tDCS 1 2 1 2 www.comascience.org

disorders of consciousness | behavioural evaluation | electrophysiology | neuroimaging | methods, ethics & quality of life | perspectives Introduction | Materials and Methods | Results | Consclusions Conclusions - Deep Brain Stimulation (Schiff et al., Nature 2008) - Amantadine (Schnakers, 2008) - Non-invasive non-pharmacological class A evidence for tDCS induced cognitive improvement in MCS www.comascience.org

THANK YOU www.comascience.org Questions to: athibaut@chu.ulg.ac.be

Responders 25 VS/UWS 2 responders 2/11 VS/UWS acute 0/14 VS/UWS chronic 30 MCS 15 responders 7/9 acute 8/21 chronic www.comascience.org

Responders: audition subscale * * Consistent movement to command Reproducible movement to command Localisation of sounds Auditory startle None pre tDCS post tDCS pre sham post sham www.comascience.org

Responders: subscales - visual * * Object recognition Reaching Visual pursuit Fixation Visual startle None pre tDCS post tDCS pre sham post sham www.comascience.org

tDCS parameters and safety U=R*I Intensity: 2mA Time: 20 minutes 2mA et 10kOhm Voltage: max 26V = 20V OK 2mA and 20kOhm Electrodes: 35cm² = 40V STOP Max: 0.1mA/cm² www.comascience.org

tDCS presumed mode of action Direct effects Modification of neuronal excitability Long term effects Modification of ion channels (Na + , Ca 2+ ) Modification of NMDA receptors efficacy Modification of inter-neurons still hypothesis Nitsche et al., J Physiol 2000 Nitsche et al., Neuroscientist 2010 www.comascience.org

tDCS critisisms Limitations:  Short term effect  Moderate clinical change  Unknown physiological effects (cathode)  Improve electrode position? www.comascience.org

Effects of sham-controlled double blind transcranial direct current - PowerPoint PPT Presentation

Effects of sham-controlled double blind transcranial direct current stimulation in patients with disorders of consciousness XXth World Congress of Neurology Marrakesh, Morocco 16 November 2011 THIBAUT Aurore PhD candidate Coma Science Group

Effects of sham-controlled double blind transcranial direct current stimulation in patients with

controlled with metformin over 28 days: a randomized, double-blind, placebo-controlled study.

REDUCE-FMR : A Sham-Controlled Randomized Trial of Transcatheter Indirect Mitral Annuloplasty in

ACC.2015 FEATURED CLINICAL RESEARCH Trial Registration ISRCTN33128015; Eudra-CT-number

ORA-D-007: Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of

PIONEER: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients

A randomized double-blind placebo-controlled phase II trial of RUcaparib MAintenance therapy for

Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human C1 Inhibitor for

The BELIEVE Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of

STICs and STONES: OV.24 A randomized phase II double-blind placebo-controlled trial of

A Phase 3, interventional, double-blind, placebo-controlled study to assess the safety and

The LAPLACE-2 Trial: A Phase 3, Double-blind, Randomized, Placebo and Ezetimibe Controlled,

BMS-927711 for the Acute Treatment of Migraine: A Double-Blind, Randomized, Placebo Controlled,

EMBRACE STEMI A phase 2a, randomized, double-blind, placebo- controlled trial to evaluate the

The MEDALIST Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of

A Double Mask Randomized Placebo- Controlled Trial of Probiotics to Lower Microbial Translocation

A multicenter, randomized, double-blind, placebo-controlled trial of Galectin-3 inhibitor

ENGOT-EN1/FANDANGO A randomised double-blind placebo-controlled phase II trial of first line

A Phase II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety

Final results of the double-blind placebo-controlled randomised phase 2 LOTUS trial of first-line

LAPLACE-TIMI 57 Primary Results y A Double-blind, Randomized, Placebo-controlled, Dose-ranging

WOMAN Trial Collaborators Aims and objectives A randomised, double blind, placebo controlled

A GPU-Accelerated Node Based Framework for Hair Simulation and Rendering Francesco Giordana

The OReO Study A Phase IIIb, Randomised, Double-blind, Placebo-controlled, multi-centre Study